By Christopher Monckton of Brenchley This column does not constitute medical advice. Check with your doctor. Many nostrums are being recommended, with varying justification, to reduce the harm from the…
Tag: SARS-Cov-2
Who is at risk from the Chinese Virus? Some hard data at last #coronavirus
By Christopher Monckton of Brenchley As the old saying goes, In God we trust: all others bring data. At last, we have some decent – if not yet peer-reviewed –…
Ministerial math, scientific skepticism and the Chinese virus
By Christopher Monckton of Brenchley Of government ministers it may be said that they seldom know how many beans make five. Frankly, numeracy is seldom their forte. Therefore, HM Government,…
Chinese virus on the shelf
By Christopher Monckton of Brenchley As a Sunday rest from the doom and gloom about the Chinese virus, here is an ingenious photographic composition from one of Britain’s leading artists.…
The Roth resolution and the Chinese virus
By Christopher Monckton of Brenchley The Marxstream media are working overtime to minimize or altogether to conceal the Chinese Communist Party’s responsibility for covering up the existence of the Chinese-virus…
Chinese virus: a pox on the experts #coronavirus
By Christopher Monckton of Brenchley It’s déjà vu all over again, and, frankly, nostalgia ain’t what it used to be. On the climate question, the totalitarians told us we must…
#coronavirus Good news: the downtrend in Chinese-virus case-growth rates continues
By Christopher Monckton of Brenchley The good news is that in most of the countries we are tracking the downtrend in the growth rates of both confirmed cases and deaths…
Untangling Flu and SARS-CoV-2 Prevalence
From JAMA Community Prevalence of SARS-CoV-2 Among Patients With Influenzalike Illnesses Presenting to a Los Angeles Medical Center in March 2020 Brad Spellberg, MD1; Meredith Haddix, MPH2; Rebecca Lee, MPH2;…
Hopeful: Summary of Wuhan #Coronavirus Therapies and Potential Cures
Guest post by Rud Istvan, In the 3/19 Wuhan virus briefing with the FDA, team Trump made much of the possibilities for two therapeutic candidates, chloroquine and remdesivir. Having now…
The danger of making #coronavirus decisions without reliable data
From STAT A fiasco in the making? As the coronavirus pandemic takes hold, we are making decisions without reliable data By John P.A. Ioannidis March 17, 2020 The current coronavirus…
You must be logged in to post a comment.